INMB Market Cap History
Below is a table of the INMB market cap history going back to 2/4/2019:

Date INMB Market Cap
2/4/201977.66M
3/25/201979.08M
5/10/2019112.17M
8/7/201983.19M
8/9/2019742.43M
11/8/201948.68M
3/3/202042.88M
5/13/202051.94M
8/5/2020159.63M
11/5/2020113.64M

Also see: INMB Shares Outstanding History
and INMB YTD Return
INMB Historical Market Cap:
+24.25% CAGR
INMB Historical Market Cap: +24.25% CAGR

Mouse over chart for data details
2/4/20193/25/20195/10/20198/7/20198/9/201911/8/20193/3/20205/13/20208/5/202011/5/2020
INmune Bio is an early stage pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where the innate immune system is not functioning normally and contributing to the patient's disease. Co.'s proprietary is to focus on the innate immune system that include natural killer cells (NK cells), myeloid derived suppressor cells (MDSC cells) and dendritic cells. Co.'s existing drug platforms are: INKmune which primes NK cells and INB03 which down regulates MDSC cells. We show 10 historical shares outstanding datapoints in our INMB shares outstanding history coverage, used to compute INMB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing INMB market cap history over the course of time is important for investors interested in comparing INMB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of INMB versus a peer is one thing; comparing INMB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like INMB can fluctuate over the course of history. With this page we aim to empower investors researching INMB by allowing them to research the INMB market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for INMB:
INMB SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
INmune Bio (INMB) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

INMD Market Cap History
INNT Market Cap History
INSP Market Cap History
INSU Market Cap History
INSW Market Cap History
INTF Market Cap History
INTZ Market Cap History
INVO Market Cap History
INZY Market Cap History
IPA Market Cap History
More Miscellaneous companies »

 

INMB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.